Shukra Pharmaceuticals Ltd Q1FY23 net profit slides QOQ to Rs. 32.79 lakhs

Shukra Pharmaceuticals Ltd has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 6.5738 crores during the period ended June 30, 2022 as compared to Rs. 8.9730 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.3279 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 0.6469 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 2.09 for the period ended June 30, 2022 as compared to Rs. 4.13 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 6.5738 crs	₹8.9730 crs	-26.74%
Net Profit	₹0.3279 crs	₹0.6469 crs	-49.31%
EPS	₹2.09	₹4.13	-49.39%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 6.5738 crores during the period ended June 30, 2022 as compared to Rs.3.1879 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.3279 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.0371 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.2.09 for the period ended June 30, 2022 as compared to Rs.0.24 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 6.5738 crs	₹3.1879 crs	106.21%
Net Profit	₹0.3279 crs	₹0.0371 crs	783.83%
EPS	₹2.09	₹0.24	770.83%

Shares of Shukra Pharmaceuticals Ltd was last trading in BSE at Rs. 185.90 as compared to the previous close of Rs. 179.20. The total number of shares traded during the day was 1059 in over 54 trades.

The stock hit an intraday high of Rs. 185.95 and intraday low of 174.20. The net turnover during the day was Rs. 192582.00.

Source : Equity Bulls

Keywords

ShukraPharmaceuticals Q1FY23 ResultUpdate